```html

Peptic Esophagitis – A Comprehensive Medical Guide

Overview

Peptic esophagitis is inflammation of the esophagus (the tube that carries food from the mouth to the stomach) caused primarily by exposure to stomach acid and digestive enzymes. The condition is also called reflux esophagitis because it is most often a consequence of gastro‑esophageal reflux disease (GERD). Chronic acid exposure damages the lining of the esophagus, leading to redness, ulceration, and sometimes scarring.

Who it affects: Peptic esophagitis can occur at any age, but it is most common in adults over 40 years. Women and men are affected roughly equally, though some studies suggest a slightly higher prevalence in males with GERD. Children with neurological impairment or those who are tube‑fed are also at increased risk.

Prevalence: According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), GERD affects up to 20 % of the U.S. population, and about 30–40 % of those individuals develop esophagitis of varying severity. Worldwide, the pooled prevalence of reflux‑related esophagitis is estimated at 10‑15 % (JAMA Netw Open, 2020).

Symptoms

The clinical picture ranges from mild discomfort to severe pain. Not every person experiences all symptoms.

• Heartburn – a burning sensation behind the breastbone, often after meals or when lying down.
• Regurgitation – sour or bitter liquid rising into the throat or mouth.
• Chest pain – may mimic angina; usually described as a pressure or burning that improves with antacids.
• Dysphagia – difficulty swallowing, feeling that food “sticks.”
• Odynophagia – painful swallowing, especially with solid foods.
• Chronic cough or hoarseness – due to acid irritation of the larynx.
• Sore throat or a sensation of a lump in the throat (globus).
• Halitosis – persistent bad breath from refluxed material.
• Vomiting of blood (hematemesis) or coffee‑ground material – indicates ulceration or bleeding.
• Weight loss – may result from fear of swallowing or chronic vomiting.

When symptoms are intermittent and mild, many patients attribute them to “heartburn” and do not seek care. Persistent or worsening symptoms warrant evaluation.

Causes and Risk Factors

Primary cause – Acid and enzyme reflux

When the lower esophageal sphincter (LES) relaxes inappropriately or is weakened, stomach contents (hydrochloric acid, pepsin, bile) flow back into the esophagus, causing chemical injury.

Secondary causes

• Medications – NSAIDs, bisphosphonates, potassium chloride, tetracyclines, and certain antibiotics can irritate the esophageal lining.
• Infections – especially in immunocompromised patients (Candida, Herpes simplex, CMV).
• Radiation therapy to the chest or neck.
• Caustic ingestion – accidental or intentional ingestion of strong acids or alkalis.

Risk factors

• Obesity (BMI ≥ 30) – increased intra‑abdominal pressure.
• Hiatal hernia – disrupts LES function.
• Pregnancy – hormonal relaxation of LES and increased pressure.
• Smoking – reduces LES tone and salivary bicarbonate production.
• Alcohol use – relaxes LES and directly irritates mucosa.
• Dietary triggers – caffeine, chocolate, mint, fatty/fried foods, citrus, tomato‑based products.
• Delayed gastric emptying (gastroparesis).
• Connective‑tissue disorders (scleroderma) that impair esophageal motility.

Diagnosis

Diagnosis is a combination of clinical assessment and objective testing.

1. Medical history & physical exam

Physicians ask detailed questions about symptom pattern, aggravating/relieving factors, medication use, and lifestyle.

2. Upper endoscopy (esophagogastroduodenoscopy – EGD)

• Gold‑standard for visualizing mucosal erythema, erosions, ulcers, and strictures.
• Biopsies are taken to rule out Barrett’s esophagus, eosinophilic esophagitis, or infection.

3. Barium swallow (esophagram)

Provides functional information—detects strictures, hiatal hernia, or motility abnormalities when endoscopy is contraindicated.

4. pH monitoring (24‑hour esophageal pH test)

Quantifies acid exposure. Often paired with impedance monitoring to detect non‑acid reflux.

5. Esophageal manometry

Measures LES pressure and peristaltic function—useful when contemplating surgical therapy.

6. Laboratory tests

Usually not needed for uncomplicated peptic esophagitis, but CBC, electrolytes, and iron studies may be ordered if bleeding anemia is suspected.

Treatment Options

Management is tiered—starting with lifestyle changes and medication, escalating to endoscopic or surgical interventions if needed.

1. Lifestyle & dietary modifications

• Elevate head of bed 6‑8 inches.
• Avoid meals within 3 hours of bedtime.
• Consume smaller, frequent meals.
• Limit trigger foods (caffeine, chocolate, mint, fried/fatty foods, citrus, tomato, alcohol).
• Maintain a healthy weight; aim for BMI < 25 kg/m².
• Quit smoking; seek cessation programs.
• Wear loose clothing to avoid abdominal pressure.

2. Medications

• Proton pump inhibitors (PPIs) – omeprazole, esomeprazole, pantoprazole, lansoprazole. Most effective for acid suppression; typical dose 20‑40 mg daily for 8‑12 weeks.
• H2‑receptor antagonists – ranitidine (withdrawn), famotidine, cimetidine. Useful for mild disease or as adjuncts.
• Antacids – calcium carbonate, magnesium/aluminium hydroxide for rapid symptomatic relief.
• Alginate‑based formulations (e.g., Gaviscon) create a protective foam barrier.
• Prokinetics – metoclopramide or erythromycin in patients with delayed gastric emptying.
• Sucralfate – coats ulcerated mucosa, may aid healing.

Long‑term PPI use should be reassessed periodically because of potential risks (bone fracture, C. diff infection, magnesium deficiency). Tapering strategies are recommended after symptom control.

3. Endoscopic therapies

• Radiofrequency ablation (RFA) – for refractory Barrett’s esophagus, occasionally used for persistent inflammation.
• Endoscopic mucosal resection or ablative therapy – for localized ulcerations or precancerous lesions.

4. Surgical options

• Laparoscopic fundoplication (Nissen or Toupet) – reinforces LES, recommended for patients with chronic GERD refractory to medication or those who prefer a medication‑free approach.
• Linx device – magnetic sphincter augmentation, an alternative for select patients.

5. Managing complications

If strictures develop, dilation (balloon or bougienage) is performed endoscopically. Persistent bleeding may need endoscopic hemostasis or, rarely, surgical intervention.

Living with Peptic Esophagitis

Daily Management Tips

• Track symptoms in a diary—note foods, timing, and severity to identify individual triggers.
• Take PPIs 30 minutes before the first meal of the day for optimal effect.
• Stay hydrated but avoid large volumes of liquid during meals; sip water between bites.
• Chew food thoroughly; soft foods (e.g., oatmeal, yogurt, smoothies) are easier on the esophagus.
• Use a pill‑splitting or crushing strategy only if recommended by your pharmacist (some PPIs are enteric‑coated).
• Maintain regular follow‑up endoscopy if you have Barrett’s changes or have had ulcerations > 6 months.
• Seek support groups—online forums often share practical coping strategies and encourage medication adherence.

Psychosocial considerations

Chronic chest discomfort can lead to anxiety or depression. Cognitive‑behavioral therapy (CBT) and stress‑reduction techniques (mindfulness, yoga) may lessen symptom perception.

Prevention

• Adopt a healthy weight and regular aerobic activity (150 min/week).
• Follow the GERD diet—high fiber, low fat, limited caffeine and alcohol.
• Never lie down immediately after eating; stay upright for at least 2‑3 hours.
• If you take NSAIDs or bisphosphonates, use them with food and plenty of water, and consider a PPI prophylaxis after discussing with your doctor.
• Screen for hiatal hernia if you have persistent symptoms; early repair can prevent progression.

Complications

When left untreated or poorly controlled, peptic esophagitis can lead to serious outcomes:

• Esophageal stricture – narrowing that causes dysphagia; often requires dilation.
• Barrett’s esophagus – metaplasia of the distal esophageal epithelium, increasing risk of adenocarcinoma (≈0.5‑1 % per year of progression).
• Esophageal ulceration and bleeding – may present as hematemesis or melena.
• Erosive esophagitis – severe inflammation that can perforate (rare but life‑threatening).
• Respiratory complications – chronic aspiration leading to bronchitis, asthma exacerbation, or pneumonia.

When to Seek Emergency Care

References

• Mayo Clinic. “Gastroesophageal reflux disease (GERD).” https://www.mayoclinic.org/...
• National Institute of Diabetes and Digestive and Kidney Diseases. “Definition & Facts for GERD.” 2023.
• American College of Gastroenterology. “Management of GERD and Barrett’s Esophagus.” gi.org
• Cleveland Clinic. “Esophagitis – Causes, Symptoms, and Treatment.” 2022.
• World Health Organization. “Global Health Estimates 2022.”
• JAMA Network Open. “Prevalence of Endoscopic Esophagitis in the United States.” 2020;3(10):e2024238.

```